Madrigal Pharmaceuticals
Harris Rotman is a seasoned regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Vice President and Head of Global Regulatory Affairs at Madrigal Pharmaceuticals, Rotman has held senior positions at various organizations, including Centessa Pharmaceuticals and SwanBio Therapeutics. Prior roles include Vice President at Endo Pharmaceuticals and Indivior, where responsibilities encompassed overseeing global regulatory affairs. Harris Rotman earned a Ph.D. in Microbiology and Molecular Virology from Jefferson Health and a B.S. in Biological Sciences from Rutgers University.
This person is not in any teams
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.